Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis

International Journal of Cardiology

Volumn 169, Issue 1, 2013, Pages 62-72

  Wu, Na ^a   Xu, Bin ^a   Xiang, Ying ^a   Wu, Long ^a   Zhang, Yao ^a   Ma, Xiangyu ^a   Tong, Shifei ^a   Shu, Maoqing ^a   Song, Zhiyuan ^a   Li, Yafei ^a   Zhong, Li ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Coronary artery bypass grafting surgery; Electrical cardioversion; Inflammatory factor; Meta analysis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR;

ATRIAL FIBRILLATION; CATHETER ABLATION; CORONARY ARTERY BYPASS GRAFTING SURGERY; ELECTRICAL CARDIOVERSION; INFLAMMATORY FACTOR; META-ANALYSIS;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; OBSERVATIONAL STUDY AS TOPIC; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886749547     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.078     Document Type: Article

References (151)

1. V. Fuster, L.E. Ryden, and D.S. Cannom 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
2. W.B. Kannel, and E.J. Benjamin Status of the epidemiology of atrial fibrillation Med Clin North Am 92 2008 17 40 [ix]
3. V. Climent, F. Marin, and L. Mainar Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation Int J Cardiol 132 2009 227 232
4. M.D. O'Neill, P. Jais, and M. Hocini Catheter ablation for atrial fibrillation Circulation 116 2007 1515 1523
5. M. Elahi, L. Hadjinikolaou, and M. Galinanes Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery Circulation 108 Suppl. 1 2003 II207 II212
6. S.S. Chugh, J.L. Blackshear, W.K. Shen, S.C. Hammill, and B.J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J Am Coll Cardiol 37 2001 371 378
7. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
8. J. Dernellis, and M. Panaretou C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation Acta Cardiol 56 2001 375 380
9. P.T. Ellinor, A. Low, K.K. Patton, M.A. Shea, and C.A. MacRae C-reactive protein in lone atrial fibrillation Am J Cardiol 97 2006 1346 1350
10. S.Y. Yao, J.M. Chu, and K.P. Chen Inflammation in lone atrial fibrillation Clin Cardiol 32 2009 94 98
11. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
12. J. Dernellis, and M. Panaretou Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation Am J Cardiol 97 2006 245 248
13. G. Casaclang-Verzosa, M.E. Barnes, and G. Blume C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly Echocardiography 27 2010 394 399
14. R.B. Schnabel, M.G. Larson, and J.F. Yamamoto Relation of multiple inflammatory biomarkers to incident atrial fibrillation Am J Cardiol 104 2009 92 96
15. R. Targonski, D. Salczynska, J. Sadowski, and L. Cichowski Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure Kardiol Pol 66 2008 729 736 [discussion 37-9]
16. I. Liuba, H. Ahlmroth, and L. Jonasson Source of inflammatory markers in patients with atrial fibrillation Europace 10 2008 848 853
17. P.L. Pellegrino, N.D. Brunetti, L. De Gennaro, L. Ziccardi, M. Grimaldi, and M.D. Biase Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset Intern Emerg Med 8 2013 123 128
18. S. Dai, S. Zhang, Y. Guo, J. Chu, W. Hua, and F. Wang C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy Clin Cardiol 32 2009 E45 E50
19. L. De Gennaro, N.D. Brunetti, D. Montrone, F. De Rosa, A. Cuculo, and M. Di Biase Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation Eur J Clin Invest 42 2012 371 375
20. D. Kaireviciute, A.D. Blann, and B. Balakrishnan Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients Thromb Haemost 104 2010 122 127
21. P.H. Gibson, B.H. Cuthbertson, and B.L. Croal Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting Am J Cardiol 105 2010 186 191
22. L. Garcia, H.E. Verdejo, and J. Kuzmicic Impaired cardiac autophagy in patients developing postoperative atrial fibrillation J Thorac Cardiovasc Surg 143 2012 451 459
23. P. Osmancik, Z. Peroutka, P. Budera, D. Herman, P. Stros, and Z. Straka Changes in cytokine concentrations following successful ablation of atrial fibrillation Eur Cytokine Netw 21 2010 278 284
24. D.I. Leftheriotis, K.T. Fountoulaki, and P.G. Flevari The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation Int J Cardiol 135 2009 361 369
25. E. Watanabe, T. Arakawa, T. Uchiyama, I. Kodama, and H. Hishida High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion Int J Cardiol 108 2006 346 353
26. A. Tveit, I. Seljeflot, I. Grundvold, M. Abdelnoor, P. Smith, and H. Arnesen Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation Am J Cardiol 99 2007 1544 1548
27. K.M. Henningsen, B. Nilsson, H. Bruunsgaard, X. Chen, B.K. Pedersen, and J.H. Svendsen Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation Scand Cardiovasc J 43 2009 285 291
28. J. Liu, P.H. Fang, S. Dibs, Y. Hou, X.F. Li, and S. Zhang High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation Pacing Clin Electrophysiol 34 2011 398 406
29. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis J Am Coll Cardiol 49 2007 1642 1648
30. O.O. Celebi, S. Celebi, A. Canbay, G. Ergun, S. Aydogdu, and E. Diker The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion Cardiology 118 2011 168 174
31. C. Falcone, M.P. Buzzi, and A. D'Angelo Apelin plasma levels predict arrhythmia recurrence in patients with persistent atrial fibrillation Int J Immunopathol Pharmacol 23 2010 917 925
32. E. Vizzardi, S. Nodari, and G. Zanini High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion Intern Emerg Med 4 2009 309 313
33. F. Lombardi, F. Tundo, S. Belletti, A. Mantero, and G.V. Melzi D'eril C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function J Cardiovasc Med (Hagerstown) 9 2008 581 588
34. E.M. Kallergis, E.G. Manios, and E.M. Kanoupakis The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation Heart 94 2008 200 204
35. E. Gomez Martinez, S. Borras Palle, and F. Valls Grima Inflammatory state in patients with atrial fibrillation before and after electrical cardioversion Med Intensiva 31 2007 126 132
36. S.K. Kim, H.N. Pak, and J.H. Park Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion Europace 11 2009 1632 1638
37. F. Naji, and M. Sabovic Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion J Negat Results Biomed 10 2011 15
38. D. Ferro, P. Franciosa, and R. Cangemi Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion Circ Arrhythm Electrophysiol 5 2012 327 333
39. K.M. Henningsen, S.K. Therkelsen, H. Bruunsgaard, K.S. Krabbe, B.K. Pedersen, and J.H. Svendsen Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion Scand J Clin Lab Invest 69 2009 425 432
40. Y. Colkesen, T. Acil, and B. Abayli Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Blood Coagul Fibrinolysis 19 2008 411 414
41. H. Ichiki, K. Orihara, and S. Hamasaki The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes J Cardiol 53 2009 127 135
42. M.R. Ki, D.G. Shin, and J.S. Park Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-beta1 decrease in atrial fibrillation Int J Cardiol 145 2010 345 346
43. A. Scridon, E. Morel, E. Nonin-Babary, N. Girerd, C. Fernandez, and P. Chevalier Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation Europace 14 2012 948 953
44. J. Li, J. Solus, and Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
45. Y.C. Qu, Y.M. Du, S.L. Wu, Q.X. Chen, H.L. Wu, and S.F. Zhou Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation Scand Cardiovasc J 43 2009 292 297
46. V. Roldan, F. Marin, and A.D. Blann Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation Eur Heart J 24 2003 1373 1380
47. J. Barani, I. Mattiasson, B. Lindblad, and A. Gottsater Cardiac function, inflammatory mediators and mortality in critical limb ischemia Angiology 57 2006 437 444
48. R.B. Neuman, H.L. Bloom, and I. Shukrullah Oxidative stress markers are associated with persistent atrial fibrillation Clin Chem 53 2007 1652 1657
49. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
50. J. Little, L. Bradley, and M.S. Bray Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations Am J Epidemiol 156 2002 300 310
51. G.A. Wells, SB, and D. O'Connell The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses 2011
52. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
53. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
54. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
55. J. Zarauza, M.J. Rodriguez Lera, and C. Farinas Alvarez Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion Rev Esp Cardiol 59 2006 125 129
56. L. You, P. Wang, J. Lv, K. Cianflone, D. Wang, and C. Zhao The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation J Huazhong Univ Sci Technolog Med Sci 30 2010 648 651
57. S.Y. Shin, J.O. Na, and H.E. Lim Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation J Cardiovasc Electrophysiol 22 2011 376 382
58. Y. Luan, Y. Guo, and S. Li Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease Europace 12 2010 1713 1718
59. K.P. Letsas, P. Korantzopoulos, and G.S. Filippatos Uric acid elevation in atrial fibrillation Hellenic J Cardiol 51 2010 209 213
60. M. Ozaydin, Y. Turker, and E. Varol Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis Int J Cardiovasc Imaging 26 2010 547 552
61. G.M. Marcus, L.M. Smith, and K. Ordovas Intracardiac and extracardiac markers of inflammation during atrial fibrillation Heart Rhythm 7 2010 149 154
62. L. Zhang, R. Ding, Y. Zhen, and Z.G. Wu Relation of urotensin II levels to lone atrial fibrillation Am J Cardiol 104 2009 1704 1707
63. C. Tsioufis, D. Syrseloudis, and A. Hatziyianni Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects Am J Hypertens 23 2010 202 207
64. L.C. Chen, J. Peng, and W.Y. Lai Association of ATP-binding cassette transporter A1 R219K polymorphism with atrial fibrillation Nan Fang Yi Ke Da Xue Xue Bao 29 2009 494 496
65. K. Toutouzas, M. Drakopoulou, and P. Dilaveris Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography Int J Cardiol 134 2009 345 350
66. Y.J. Qian, X.J. Xiao, T.X. Luo, P. Zhu, and H.Z. Sao Study on levels of angiotensin converting enzyme and C-reactive protein in peripheral blood of mitral valve replacement preoperative patients with atrial fibrillation Sichuan Da Xue Xue Bao Yi Xue Ban 39 2008 122 125
67. G.M. Marcus, M.A. Whooley, D.V. Glidden, L. Pawlikowska, J.G. Zaroff, and J.E. Olgin Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the heart and soul study Am Heart J 155 2008 303 309
68. B. Pirat, I. Atar, and C. Ertan Comparison of C-reactive protein levels in patients who do and do not develop atrial fibrillation during electrophysiologic study Am J Cardiol 100 2007 1552 1555
69. M.T. Selcuk, H. Selcuk, and O. Maden Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis J Heart Valve Dis 16 2007 468 474
70. H.M. Badran, and M.E. Mahfouz Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and atrial fibrillation due to ischemic origin: is there a link? Eur J Cardiovasc Prev Rehabil 14 2007 518 520
71. M. Hammwohner, A. Ittenson, and J. Dierkes Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation Exp Biol Med (Maywood) 232 2007 581 589
72. K. Okamura, S. Miura, and B. Zhang Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation Circ J 71 2007 214 219
73. O. Gedikli, A. Dogan, and I. Altuntas Inflammatory markers according to types of atrial fibrillation Int J Cardiol 120 2007 193 197
74. E. Hatzinikolaou-Kotsakou, D. Tziakas, and A. Hotidis Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation Am J Cardiol 97 2006 659 661
75. C.H. Wang, D.Y. Hu, and C.Z. Tang Changes of interleukin-1beta and tumor necrosis factor-alpha of right atrial appendages in patients with rheumatic valvular disease complicated with chronic atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 33 2005 522 525
76. T. Watanabe, Y. Takeishi, and O. Hirono C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation Heart Vessels 20 2005 45 49
77. S.N. Psychari, T.S. Apostolou, L. Sinos, E. Hamodraka, G. Liakos, and D.T. Kremastinos Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation Am J Cardiol 95 2005 764 767
78. F.W. Asselbergs, M.P. van den Berg, G.F. Diercks, W.H. van Gilst, and D.J. van Veldhuisen C-reactive protein and microalbuminuria are associated with atrial fibrillation Int J Cardiol 98 2005 73 77
79. J.L. Anderson, C.A. Allen Maycock, and D.L. Lappe Frequency of elevation of C-reactive protein in atrial fibrillation Am J Cardiol 94 2004 1255 1259
80. D.S. Conway, P. Buggins, E. Hughes, and G.Y. Lip Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation Am J Cardiol 94 2004 508 510
81. D.S. Conway, P. Buggins, E. Hughes, and G.Y. Lip Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation J Am Coll Cardiol 43 2004 2075 2082
82. F.L. Li-Saw-Hee, A.D. Blann, and G.Y. Lip Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation Am J Cardiol 86 2000 795 797 [A9]
83. S. Mondillo, L. Sabatini, and E. Agricola Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation Int J Cardiol 75 2000 227 232
84. D. Feng, R.B. D'Agostino, and H. Silbershatz Hemostatic state and atrial fibrillation (the Framingham offspring study) Am J Cardiol 87 2001 168 171
85. F.L. Li-Saw-Hee, A.D. Blann, D. Gurney, and G.Y. Lip Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function Eur Heart J 22 2001 1741 1747
86. S. Kamath, B.S. Chin, A.D. Blann, and G.Y. Lip A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation Blood Coagul Fibrinolysis 13 2002 627 636
87. D.S. Conway, J. Heeringa, and D.A. Van Der Kuip Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam study Stroke 34 2003 413 417
88. Y. Wang, X. Hou, and Y. Li Association between transforming growth factor beta1 polymorphisms and atrial fibrillation in essential hypertensive subjects J Biomed Sci 17 2010 23
89. T. Liu, X. Zhang, P. Korantzopoulos, S. Wang, and G. Li Uric acid levels and atrial fibrillation in hypertensive patients Intern Med 50 2011 799 803
90. J. Fan, H. Cao, and L. Su NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation J Interv Card Electrophysiol 33 2012 93 100
91. L. Liu, J. Lee, and G. Fu Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation Int Heart J 53 2012 221 224
92. G.Y. Lip, G.D. Lowe, A. Rumley, and F.G. Dunn Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis Am Heart J 131 1996 724 730
93. E. Hatzinikolaou-Kotsakou, Z. Kartasis, and D. Tziakas Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations? J Thromb Thrombolysis 16 2003 155 161
94. T. Cheng, X.F. Wang, Y.T. Hou, and L. Zhang Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines Mol Med Rep 6 2012 581 584
95. R.B. Schnabel, M.G. Larson, and J.F. Yamamoto Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community Circulation 121 2010 200 207
96. C. Antoniades, T. Van-Assche, and C. Shirodaria Preoperative sCD40L levels predict risk of atrial fibrillation after off-pump coronary artery bypass graft surgery Circulation 120 2009 S170 S176
97. H. Gasparovic, I. Burcar, and T. Kopjar NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery Eur J Cardiothorac Surg 37 2010 100 105
98. Y.S. Choi, J.K. Shim, S.W. Hong, D.H. Kim, J.C. Kim, and Y.L. Kwak Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement Eur J Cardiothorac Surg 36 2009 838 843
99. M.L. Fontes, D. Amar, and A. Kulak Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery J Cardiothorac Vasc Anesth 23 2009 484 487
100. A. Sezai, M. Hata, and T. Niino Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention J Thorac Cardiovasc Surg 137 2009 895 900
101. M. Oc, H.I. Ucar, and A. Pinar Heat shock protein70: a new marker for subsequent atrial fibrillation development? Artif Organs 32 2008 846 850
102. S. Ziabakhsh-Tabari Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery? Saudi Med J 29 2008 1429 1431
103. S. Canbaz, H. Erbas, S. Huseyin, and E. Duran The role of inflammation in atrial fibrillation following open heart surgery J Int Med Res 36 2008 1070 1076
104. H.I. Ucar, M. Tok, and E. Atalar Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery Heart Surg Forum 10 2007 E131 E135
105. C.W. Hogue Jr., C.A. Palin, and R. Kailasam C-reactive protein levels and atrial fibrillation after cardiac surgery in women Ann Thorac Surg 82 2006 97 102
106. J. Cosgrave, J.B. Foley, and R. Kelly Perioperative serum inflammatory response and the development of atrial fibrillation after coronary artery bypass surgery Heart 91 2005 1475 1476
107. B. Lo, R. Fijnheer, A.P. Nierich, P. Bruins, and C.J. Kalkman C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization Ann Thorac Surg 79 2005 1530 1535
108. K. Mandal, E. Torsney, J. Poloniecki, A.J. Camm, Q. Xu, and M. Jahangiri Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation Ann Thorac Surg 79 2005 865 871 [discussion 71]
109. K. Mandal, M. Jahangiri, M. Mukhin, J. Poloniecki, A.J. Camm, and Q. Xu Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation Circulation 110 2004 2588 2590
110. H. Gungor, M.F. Ayik, and B. Kirilmaz Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery Coron Artery Dis 22 2011 484 490
111. A. Buob, J. Jung, S. Siaplaouras, H.R. Neuberger, and C. Mewis Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation Pacing Clin Electrophysiol 29 2006 559 563
112. J. Cosgrave, J.B. Foley, K. Bahadur, K. Bennett, P. Crean, and M.J. Walsh Inflammatory markers are not associated with outcomes following elective external cardioversion Int J Cardiol 110 2006 373 377
113. J.F. Malouf, R. Kanagala, and F.O. Al Atawi High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion J Am Coll Cardiol 46 2005 1284 1287
114. P. Korantzopoulos, T.M. Kolettis, E. Kountouris, K. Siogas, and J.A. Goudevenos Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? Int J Clin Pract 59 2005 881 885
115. O. Wazni, D.O. Martin, and N.F. Marrouche C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion Heart 91 2005 1303 1305
116. Y. Okumura, I. Watanabe, and T. Nakai Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence J Cardiovasc Electrophysiol 22 2011 987 993
117. Y.J. Lin, H.M. Tsao, and S.L. Chang Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation Am J Cardiol 105 2010 495 501
118. T. Koyama, Y. Sekiguchi, and H. Tada Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation Am J Cardiol 103 2009 1249 1254
119. N. Lellouche, F. Sacher, and M. Wright Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation Europace 11 2009 662 664
120. K.P. Letsas, R. Weber, and G. Burkle Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation Europace 11 2009 158 163
121. M. Rotter, P. Jais, and M.C. Vergnes Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation J Am Coll Cardiol 47 2006 1231 1233
122. W. Garrey Auricular fibrillation Physiol Rev 4 1924 215 250
123. G.K. Moe, W.C. Rheinboldt, and J.A. Abildskov A computer model of atrial fibrillation Am Heart J 67 1964 200 220
124. M.A. Allessie, W.L. FIM Bonke, and J. Hollen Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation 1985 Grune&Stratton New York
125. M. Haissaguerre, P. Jais, and D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
126. A. Shiroshita-Takeshita, B.J. Brundel, and S. Nattel Atrial fibrillation: basic mechanisms, remodeling and triggers J Interv Card Electrophysiol 13 2005 181 193
127. W.B. Kannel, and E.J. Benjamin Current perceptions of the epidemiology of atrial fibrillation Cardiol Clin 27 2009 13 24 [vii]
128. A. Kourliouros, and A.J. Camm Does inflammation influence atrial fibrillation recurrence following catheter ablation? Europace 11 2009 135 137
129. J. Wu, and P.B. Corr Influence of long-chain acylcarnitines on voltage-dependent calcium current in adult ventricular myocytes Am J Physiol 263 1992 H410 H417
130. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
131. M. Acevedo, R. Corbalan, S. Braun, J. Pereira, C. Navarrete, and I. Gonzalez C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia" Int J Cardiol 108 2006 326 331
132. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
133. S.D. de Ferranti, and N. Rifai C-reactive protein: a nontraditional serum marker of cardiovascular risk Cardiovasc Pathol 16 2007 14 21
134. D.J. Rader Inflammatory markers of coronary risk N Engl J Med 343 2000 1179 1182
135. C.A. Goudis, E.M. Kallergis, and P.E. Vardas Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation Europace 14 2012 623 630
136. F. Gramley, J. Lorenzen, E. Koellensperger, K. Kettering, C. Weiss, and T. Munzel Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway Int J Cardiol 143 2010 405 413
137. H. Xiao, H. Lei, S. Qin, K. Ma, and X. Wang TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease Clin Cardiol 33 2010 149 156
138. S. Verheule, T. Sato, and Tt Everett Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1 Circ Res 94 2004 1458 1465
139. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor beta in human disease N Engl J Med 342 2000 1350 1358
140. A. Anselmi, G. Possati, and M. Gaudino Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg 88 2009 326 333
141. B. Maesen, J. Nijs, J. Maessen, M. Allessie, and U. Schotten Post-operative atrial fibrillation: a maze of mechanisms Europace 14 2012 159 174
142. R.N. Goldstein, and B.S. Stambler New antiarrhythmic drugs for prevention of atrial fibrillation Prog Cardiovasc Dis 48 2005 193 208
143. T. Liu, G.P. Li, and T.G. Huang Anti-inflammatory therapies in atrial fibrillation Int J Cardiol 104 2005 359 360
144. E.W. Kuhn, O.J. Liakopoulos, and S. Stange Preoperative statin therapy in cardiac surgery: a meta-analysis of 90 000 patients Eur J Cardiothorac Surg 2013 10.1093/ejcts/ezt181
145. L. Fauchier, N. Clementy, and D. Babuty Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials Curr Opin Cardiol 28 2013 7 18
146. L. Yin, Z. Wang, Y. Wang, G. Ji, and Z. Xu Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery Heart Lung Circ 19 2010 579 583
147. L. Loffredo, F. Angelico, L. Perri, and F. Violi Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis BMC Cardiovasc Disord 12 2012 107
148. X. Zhou, J.L. Du, J. Yuan, and Y.Q. Chen Statin therapy is beneficial for the prevention of atrial fibrillation in patients with coronary artery disease: a meta-analysis Eur J Pharmacol 707 2013 104 111
149. X. Zhou, J.L. Du, J. Yuan, and Y.Q. Chen Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis Int J Med Sci 10 2013 198 205
150. M. Ozaydin Atrial fibrillation and inflammation World J Cardiol 2 2010 243 250
151. J. Lau, J.P. Ioannidis, N. Terrin, C.H. Schmid, and I. Olkin The case of the misleading funnel plot BMJ 333 2006 597 600